Inflammatory conversion of quiescent osteoblasts by metastatic breast cancer cells through pERK1/2 aggravates cancer-induced bone destruction
Jungho Back(Yale University), Francis Y. Lee(Yale University)
Cited by 18
Related Papers
Extranuclear Functions of ER Impact Invasive Migration and Metastasis by Breast Cancer Cells
|Cancer Research|2010|89
Activities of SYK and PLCγ2 Predict Apoptotic Response of CLL Cells to SRC Tyrosine Kinase Inhibitor Dasatinib
|Clinical Cancer Research|2010|60
Discovery and Evaluation of 4-(2-(4-chloro-1<i>H</i>-pyrazol-1-yl)ethylamino)-3-(6-(1-(3-fluoropropyl)piperidin-4-yl)-4-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)pyridin-2(1<i>H</i>)-one (BMS-695735), an Orally Efficacious Inhibitor of Insulin-like Growth Factor-1 Receptor Kinase with Broad Spectrum in Vivo Antitumor Activity
|Journal of Medicinal Chemistry|2008|33
SAR of PXR transactivation in benzimidazole-based IGF-1R kinase inhibitors
|Bioorganic & Medicinal Chemistry Letters|2010|25
Calreticulin inhibits inflammation‐induced osteoclastogenesis and bone resorption
|Journal of Orthopaedic Research®|2017|23